Exploring therapeutic strategies to prevent further damage to, or accelerate restoration of the glycocalyx layer may help to reduce morbidity associated with plasma leak in dengue; SDC1 and/or PBR hf may serve as useful surrogate endpoints in future clinical trials. Here, SDC1 is linked to dengue disease.